Genetic evidence that SOST inhibits WNT signaling in the limb
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
SOST is a negative regulator of bone formation and mutations in human SOST are responsible for sclerosteosis. In addition to high bone mass, sclerosteosis patients occasionally display hand defects, suggesting that SOST may function embryonically. Here we report that overexpression of SOST leads to loss of posterior structures of the zeugopod and autopod by perturbing anterior-posterior and proximal-distal signaling centers in the developing limb. Mutant mice that overexpress SOST in combination with Grem1 and Lrp6 mutations display more severe limb defects than single mutants alone, while Sost-/- significantly rescues the Lrp6-/- skeletal phenotype, signifying that SOST gain-of-function impairs limb patterning by inhibition of WNT signaling through LRP5/6.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147 · cited 4×
“…with SOST's role during bone metabolism where osteocytes deeply buried in the bone secrete SOST, which travels to the surface of the bone where osteoblasts reside and inhibit their mineralization function (Balemans et al., 2001;Brunkow et al., 2001;Li et al., 2008a;van Bezooijen et al., 2004).”
BackgroundResultInfluentialBrunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011 · cited 4×
“Examination of SOST and its paralog, SOSTDC1 has revealed that these molecules can behave both as BMP-(Kassai et al., 2005; Laurikkala et al., 2003; Winkler et al., 2003) and WNTantagonists (Ellies et al., 2006; Itasaki et al., 2003; van Bezooijen et al., 2004; van Bezooijen et al., 2007; Lin et al., 2009), generating…”
BackgroundInfluentialFunction and biological roles of the Dickkopf family of Wnt modulators
Niehrs, C. (2006) · Oncogene · doi:10.1038/sj.onc.1210054 · Cited by 995 · cited 2×
“…frizzled related proteins (SFRP) directly bind to WNT ligands and prevent them from binding to the receptor, while members of the Dickkopf family (DKK) interact with the two WNT co-receptors, low density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) (Niehrs, 2006; Pinzone et al., 2009).”
BackgroundGenomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
Loots, G. G., Kneissel, M., Keller, H., Baptist, M., Chang, J., Collette, N. M., Ovcharenko, D., Plajzer-Frick, I., & Rubin, E. M. (2005) · Genome Research · doi:10.1101/gr.3437105 · Cited by 442 · cited 6×
“Materials and Methods Generation of compound mice Sosttg, Grem1, Lrp5, Lrp6, BatGal and Sost mutant mice have been previously described (Holmen et al., 2004; Khokha et al., 2003; Li et al., 2008a; Loots et al., 2005; Maretto et al., 2003).”
BackgroundMethodSelf-citationWise, a context-dependent activator and inhibitor of Wnt signalling
Itasaki, N., Jones, C. M., Mercurio, S., Rowe, A., Domingos, P. M., Smith, J. C., & Krumlauf, R. (2003) · Development · doi:10.1242/dev.00674 · Cited by 321 · cited 2×
“In contrast, we found that SOST shows strong interactions with the WNT pathway, consistent with SOST acting as a WNT inhibitor via its interactions with the WNT co-receptors LRP5 and LRP6 (Ellies et al., 2006; Itasaki et al., 2003; Li et al., 2005).”
Background
Cited by
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
Secreted and transmembrane wnt inhibitors and activators
Cruciat, C.-M., & Niehrs, C. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015081 · Cited by 646
Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
Ke, H. Z., Richards, W. G., Li, X., & Ominsky, M. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1060 · Cited by 402
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Leupin, O., Piters, E., Halleux, C., Hu, S., Kramer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Ramos Fuentes, F. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190330 · Cited by 301
The Regulation of Valvular and Vascular Sclerosis by Osteogenic Morphogens
Boström, K. I., Rajamannan, N. M., & Towler, D. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.234278 · Cited by 257
Metadata
- Authors
- Collette, N. M., Genetos, D. C., Murugesh, D., Harland, R. M., & Loots, G. G.
- Venue
- Developmental Biology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 342
- Issue
- 2
- Pages
- 169-179
- ISSN
- 0012-1606 (ISSN-L)
- OpenAlex
- W2084898060
- Cited by
- 49
- References
- 7
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic evidence that SOST inhibits WNT signaling in the limb. https://app.cochat.ai/papers/10.1016/j.ydbio.2010.03.021
- The paper
- Collette, N. M., Genetos, D. C., Murugesh, D., Harland, R. M., & Loots, G. G. (2010). Genetic evidence that SOST inhibits WNT signaling in the limb. Developmental Biology. https://doi.org/10.1016/j.ydbio.2010.03.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.